Voloridge Investment Management, LLC Acadia Pharmaceuticals Inc Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 1,308,993 shares of ACAD stock, worth $22.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,308,993

Previous 1,601,216 18.25%

Holding current value

$22.5 Million

Previous $26 Million 22.58%

% of portfolio

0.08%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $4.42 Million - $5.59 Million	-292,223 Reduced 18.25%	1,308,993 $20.1 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $3.56 Million - $4.48 Million	243,243 Added 17.91%	1,601,216 $26 Million
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $1.35 Million - $2.34 Million	75,796 Added 5.91%	1,357,973 $25.1 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $4.94 Million - $7.55 Million	237,676 Added 22.75%	1,282,177 $40.1 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $11 Million - $17.7 Million	529,927 Added 102.98%	1,044,501 $21.8 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $5.32 Million - $7.66 Million	298,642 Added 138.3%	514,574 $12.3 Million
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $4.72 Million - $6.05 Million	-289,172 Reduced 57.25%	215,932 $4.06 Million
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $2.83 Million - $3.72 Million	-199,461 Reduced 28.31%	505,104 $8.04 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $4.76 Million - $6.17 Million	-337,690 Reduced 32.4%	704,565 $11.5 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $8.03 Million - $16.8 Million	617,594 Added 145.43%	1,042,255 $14.7 Million
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $2.07 Million - $2.72 Million	98,748 Added 30.3%	424,661 $10.3 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $7.45 Million - $12 Million	-443,759 Reduced 57.66%	325,913 $7.61 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $2.67 Million - $4.19 Million	169,240 Added 28.19%	769,672 $12.8 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $755,280 - $1.07 Million	-38,932 Reduced 6.09%	600,432 $14.6 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $16 Million - $35.2 Million	639,364 New	639,364 $16.5 Million
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $3.78 Million - $5.36 Million	-104,352 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $2.05 Million - $4.06 Million	92,192 Added 758.16%	104,352 $3.76 Million
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $504,131 - $607,898	-21,618 Reduced 64.0%	12,160 $325,000
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $546,190 - $924,841	33,778 New	33,778 $907,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.78B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Acadia Pharmaceuticals Inc Transaction History